VRTX
Vertex Pharmaceuticals Incorporated
Stock
$504.73−2.01 (−0.40%)Close Oct 2, 2026
- Revenue, 2025
- $12.0B
- YoY, 2025
- +8.9%
- 5-year CAGR
- +14.1%
- 10-year CAGR
- +27.8%
Revenue
Revenue by fiscal year
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $12.0B | +8.9% |
| 2024 | $11.0B | +11.7% |
| 2023 | $9.9B | +10.5% |
| 2022 | $8.9B | +17.9% |
| 2021 | $7.6B | +22.1% |
| 2020 | $6.2B | +49.1% |
| 2019 | $4.2B | +36.6% |
| 2018 | $3.0B | +22.5% |
| 2017 | $2.5B | +46.2% |
| 2016 | $1.7B | +64.9% |
| 2015 | $1.0B | +77.9% |
| 2014 | $580M | −52.1% |
| 2013 | $1.2B | −20.6% |
| 2012 | $1.5B | +8.3% |
| 2011 | $1.4B | +883.9% |
| 2010 | $143M | +40.7% |
| 2009 | $102M | −41.9% |
| 2008 | $176M | — |